F&P Healthcare: FY20 Preview — How Good Is Good Enough?
F&P Healthcare FY20 Preview — How Good is Good Enough? UNDERPERFORM We already know FY20 will be a strong year for F&P Healthcare (FPH) and...
96 Views
F&P Healthcare: Unmasking ResMed’s 3Q20 Result
F&P Healthcare Unmasking ResMed’s 3Q20 Result UNDERPERFORM Insights from ResMed's (RMD) 3Q20 result support our view of strong tailwinds for...
107 Views
Equity Strategy: COVID-19 Winners, Losers, and Big Losers
Equity Strategy COVID-19 Winners, Losers, and Big Losers The impact of COVID-19 will be far reaching and very significant across our companies...
569 Views
F&P Healthcare: COVID-19 and Currency Boost
F&P Healthcare COVID-19 and Currency Boost UNDERPERFORM F&P Healthcare's (FPH) FY20 upgrade cycle continues, with a further ~5% uplift to...
493 Views
F&P Healthcare: Unmasking ResMed’s 2Q20 Result
F&P Healthcare Unmasking ResMed’s 2Q20 Result Recent data points continue to support market share gains for ResMed (RMD) in the Homecare...
739 Views